MedPath

The retrospective study for Vonoprazan, clarithromycin, and metronidazole regimen for Helicobacter pylori eradication therapy for patients with penicillin allergy in view of clarithromycin-resistance

Not Applicable
Conditions
Helicobacter pylori for patients with penicillin allergy
Registration Number
JPRN-UMIN000046547
Lead Sponsor
Aichi-medical university of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

In the case that the current infection of Helicobacter pylori cannot be confirmed If you do not wish to pay for your own treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of different treatment methods (proton pump inhibitor/bonoprazole + clarithromycin + metronidazole, bonoprazole + metronidazole + sitafloxatin) for penicillin-allergic Helicobacter spp. positive patients at our hospital(To be determined by urea breath test at least 2 months after completion of administration)
Secondary Outcome Measures
NameTimeMethod
Safety of Treatment Comparison of the difference in efficacy of the following eradication treatments in patients treated with bonoprazan, clarithromycin, and metronidazole with and without clarithromycin resistance
© Copyright 2025. All Rights Reserved by MedPath